论文信息 - Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial. - 字舞流文

Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.

A. Bleyer | F. Cabanillas | L. Medeiros | A. Goy | F. Hagemeister | B. Pro | M. Rodriguez | A. Sarris | J. Romaguera | B. Samuels | O. Mesina | A. Phan | P. Mclaughlin